Detection of the initial site of Toxoplasma gondii reactivation in brain tissue

International Journal for Parasitology

Volumn 38, Issue 5, 2008, Pages 601-607

  Takashima, Yasuhiro ^a   Suzuki, Kazuhiko ^b   Xuan, Xuenan ^c   Nishikawa, Yoshifumi ^c   Unno, Akihiro ^a   Kitoh, Katsuya ^a  

^a GIFU UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Brain tissue; Fluorescent protein; Initial site; Reactivation; Stage conversion; Toxoplasma gondii

Indexed keywords

DEXAMETHASONE; MEMBRANE ANTIGEN; RED FLUORESCENT PROTEIN;

BRAIN; DETECTION METHOD; FLUORESCENCE; PARASITE; PROTEIN; PROTOZOAN; REACTIVATION; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CYST; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PROMOTER REGION; PROTEIN EXPRESSION; TACHYZOITE; TOXOPLASMA GONDII; VERO CELL;

ANIMALS; BRAIN; DEXAMETHASONE; FEMALE; LUMINESCENT AGENTS; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CEREBRAL; VIRULENCE;

MUS; TOXOPLASMA GONDII;

EID: 39449135361     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2007.09.017     Document Type: Article

References (29)

1. Bohne W., Hunter C.A., White M.W., Ferguson D.J., Gross U., and Roos D.S. Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii. Mol. Biochem. Parasitol. 92 (1998) 291-301
2. Dao A., Soete M., Sergent V., Deslee D., Fortier B., and Dubremetz J.F. Potential of beta-galactosidase-expressing Toxoplasma gondii for in situ localization and observation of rare stages of the parasite life cycle. Parasitol. Res. 88 (2002) 69-72
3. Djurkovic-Djakovic O., and Milenkovic V. Murine model of drug-induced reactivation of Toxoplasma gondii. Acta Protozool. 40 (2001) 99-106
4. Donald R.G., and Roos D.S. Stable molecular transform ation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc. Natl. Acad. Sci. USA 90 (1993) 11703-11707
5. Dzierszinski F., Nishi M., Ouko L., and Roos D.S. Dynamics of Toxoplasma gondii differentiation. Eukaryot. Cell 3 (2004) 992-1003
6. Frenkel J.K., and Escajadillo A. Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis. Am. J. Trop. Med. Hyg. 36 (1987) 517-522
7. Fux B., Rodrigues C.V., Portela R.W., Silva N.M., Su C., Sibley D., Vitor R.W., and Gazzinelli R.T. Role of cytokines and major histocompatibility complex restriction in mouse resistance to infection with a natural recombinant strain (type I-III) of Toxoplasma gondii. Infect. Immun. 71 (2003) 6392-6401
8. Gazzinelli R.T., Eltoum I., Wynn T.A., and Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151 (1993) 3672-3681
9. Gazzinelli R.T., Hartley J.W., Fredrickson T.N., Chattopadhyay S.K., Sher A., and Morse H.C.3rd. Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infect. Immun. 60 (1992) 4394-4401
10. Kang H., and Suzuki Y. Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain. Infect. Immun. 69 (2001) 2920-2927
11. Khan I.A., Green W.R., Kasper L.H., Green K.A., and Schwartzman J.D. Immune CD8(+) T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host. Infect Immun. 67 (1999) 5869-5876
12. Kim S.K., Karasov A., and Boothroyd J.C. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine. Infect. Immun. 75 (2007) 1626-1634
13. Luft B.J., and Remington J.S. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15 (1992) 211-222
14. Nishikawa Y., Kawase O., Vielemeyer O., Suzuki H., Joiner K.A., Xuan X., and Nagasawa H. Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors. Parasite Immunol. 29 (2007) 375-385
15. Nishikawa Y., Xuenan X., Makala L., Vielemeyer O., Joiner K.A., and Nagasawa H. Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma. Int. J. Parasitol. 33 (2003) 1525-1535
16. Pomeroy C., Kline S., Jordan M.C., and Filice G.A. Reactivation of Toxoplasma gondii by cytomegalovirus disease in mice: antimicrobial activities of macrophages. J. Infect. Dis. 160 (1989) 211-305
17. Reiter-Owona I., Seitz H., Gross U., Sahm M., Rockstroh J.K., and Seitz H.M. Is stage conversion the initiating event for reactivation of Toxoplasma gondii in brain tissue of AIDS patients?. J. Parasitol. 86 (2000) 531-536
18. Silva N.M., Gazzinelli R.T., Silva D.A., Ferro E.A., Kasper L.H., and Mineo J.R. Expression of Toxoplasma gondii-specific heat shock protein 70 during In vivo conversion of bradyzoites to tachyzoites. Infect. Immun. 66 (1998) 3959-3963
19. Singh U., Brewer J.L., and Boothroyd J.C. Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction. Mol. Microbiol. 44 (2002) 721-733
20. Soete M., Fortier B., Camus D., and Dubremetz J.F. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. Exp. Parasitol. 76 (1993) 259-264
21. Sumyuen M.H., Garin Y.J., and Derouin F. Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis. Parasitol. Res. 82 (1996) 681-686
22. Vanchinathan P., Brewer J.L., Harb O.S., Boothroyd J.C., and Singh U. Disruption of a locus encoding a nucleolar zinc finger protein decreases tachyzoite-to-bradyzoite differentiation in Toxoplasma gondii. Infect. Immun. 73 (2005) 6680-6688
23. Vollmer T.L., Waldor M.K., Steinman L., and Conley F.K. Depletion of T-4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS. J. Immunol. 138 (1987) 3737-3741
24. Wang X., Claflin J., Kang H., and Suzuki Y. Importance of CD8(+)Vbeta8(+) T cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice. J. Interferon. Cytokine Res. 25 (2005) 338-344
25. Wang X., Kang H., Kikuchi T., and Suzuki Y. Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Infect. Immun. 72 (2004) 4432-4438
26. Wang X., Michie S.A., Xu B., and Suzuki Y. Importance of IFN-gamma-mediated expression of endothelial VCAM-1 on recruitment of CD8(+) T Cells into the brain during chronic infection with Toxoplasma gondii. J. Interferon. Cytokine. Res. 27 (2007) 329-338
27. Yap G., Pesin M., and Sher A. IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165 (2000) 628-631
28. Zenner L., Foulet A., Caudrelier Y., Darcy F., Gosselin B., Capron A., and Cesbron-Delauw M.F. Infection with Toxoplasma gondii RH and Prugniaud strains in mice, rats and nude rats: kinetics of infection in blood and tissues related to pathology in acute and chronic infection. Pathol. Res. Pract. 195 (1999) 475-485
29. Zhang, G.H., Vu, H.T.T., Battur, B., Zhou, J.L., Zhang, H.S., Liao, M., Kawase, O., Lee, E.G., Dautu, G., Igarashi, M., Nishikawa, Y., Zuan, X. 2007. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice. J. Parasitol.in press.